1. Home
  2. IPHA vs SPCE Comparison

IPHA vs SPCE Comparison

Compare IPHA & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.92

Market Cap

165.3M

Sector

Health Care

ML Signal

HOLD

Logo Virgin Galactic Holdings Inc.

SPCE

Virgin Galactic Holdings Inc.

N/A

Current Price

$2.93

Market Cap

331.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
IPHA
SPCE
Founded
1999
2017
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
165.3M
331.6M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
IPHA
SPCE
Price
$1.92
$2.93
Analyst Decision
Strong Buy
Hold
Analyst Count
4
5
Target Price
$5.75
$3.06
AVG Volume (30 Days)
52.7K
6.6M
Earning Date
03-26-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.84
EPS
N/A
N/A
Revenue
N/A
$1,544,000.00
Revenue This Year
$180.36
$2,270.73
Revenue Next Year
N/A
$880.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.18
$2.13
52 Week High
$2.71
$8.90

Technical Indicators

Market Signals
Indicator
IPHA
SPCE
Relative Strength Index (RSI) 41.28 47.24
Support Level $1.67 $2.84
Resistance Level $1.95 $3.39
Average True Range (ATR) 0.08 0.13
MACD -0.05 -0.01
Stochastic Oscillator 0.00 20.90

Price Performance

Historical Comparison
IPHA
SPCE

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

Share on Social Networks: